Biomedical Engineering, Oregon Health & Science University, Portland, OR 97239, USA.
Health Phys. 2010 Sep;99(3):413-9. doi: 10.1097/HP.0b013e3181ce5f3e.
Self-assembled monolayer on mesoporous supports (SAMMS) are hybrid materials created from attachment of organic moieties onto very high surface area mesoporous silica. SAMMS with surface chemistries including three isomers of hydroxypyridinone, diphosphonic acid, acetamide phosphonic acid, glycinyl urea, and diethylenetriamine pentaacetate (DTPA) analog were evaluated for chelation of actinides ((239)Pu, (241)Am, uranium, thorium) from blood. Direct blood decorporation using sorbents does not have the toxicity or renal challenges associated with traditional chelation therapy and may have potential applications for critical exposure cases, reduction of nonspecific dose during actinide radiotherapy, and for sorbent hemoperfusion in renal insufficient patients, whose kidneys clear radionuclides at a very slow rate. Sorption affinity (K(d)), sorption rate, selectivity, and stability of SAMMS were measured in batch contact experiments. An isomer of hydroxypyridinone (3,4-HOPO) on SAMMS demonstrated the highest affinity for all four actinides from blood and plasma and greatly outperformed the DTPA analog on SAMMS and commercial resins. In batch contact, a fifty percent reduction of actinides in blood was achieved within minutes, and there was no evidence of protein fouling or material leaching in blood after 24 h. The engineered form of SAMMS (bead format) was further evaluated in a 100-fold scaled-down hemoperfusion device and showed no blood clotting after 2 h. A 0.2 g quantity of SAMMS could reduce 50 wt.% of 100 ppb uranium in 50 mL of plasma in 18 min and that of 500 dpm mL(-1) in 24 min. 3,4-HOPO-SAMMS has a long shelf-life in air and at room temperature for at least 8 y, indicating its feasibility for stockpiling in preparedness for an emergency. The excellent efficacy and stability of SAMMS materials in complex biological matrices suggest that SAMMS can also be used as orally administered drugs and for wound decontamination. By changing the organic groups of SAMMS, they can be used not only for actinides but also for other radionuclides. By using the mixture of these SAMMS materials, broad spectrum decorporation of radionuclides is very feasible.
介孔载体上的自组装单分子层(SAMMS)是通过将有机基团附着到具有极高比表面积的介孔硅上来制备的杂化材料。评估了具有三种羟基吡啶酮异构体、二膦酸、乙酰氨基膦酸、甘氨酰脲和二乙三胺五乙酸(DTPA)类似物的表面化学物质,以从血液中螯合锕系元素((239)Pu、(241)Am、铀、钍)。使用吸附剂直接从血液中除去放射性核素不会产生与传统螯合疗法相关的毒性或肾脏问题,并且可能具有用于危急暴露情况的潜在应用,减少放射性核素治疗期间的非特异性剂量,以及用于肾功能不全患者的吸附剂血液灌流,其肾脏以非常缓慢的速度清除放射性核素。在批量接触实验中测量了 SAMMS 的吸附亲和力(K(d))、吸附速率、选择性和稳定性。SAMMS 上的一种羟基吡啶酮异构体(3,4-HOPO)对血液和血浆中的所有四种锕系元素表现出最高的亲和力,并且大大优于 SAMMS 和商业树脂上的 DTPA 类似物。在批量接触中,在几分钟内即可实现血液中锕系元素的 50%减少,并且在 24 小时后血液中没有发现蛋白质污染或材料浸出的证据。经过工程改造的 SAMMS(珠状形式)在 100 倍缩小的血液灌流装置中进一步进行了评估,并且在 2 小时后没有发生血液凝固。0.2 克 SAMMS 可在 18 分钟内从 50 毫升血浆中减少 50 wt.%的 100 ppb 铀,在 24 分钟内减少 500 dpm mL(-1)的铀。3,4-HOPO-SAMMS 在空气和室温下至少 8 年的保质期长,表明其在紧急情况下进行储备的可行性。SAMMS 材料在复杂生物基质中的优异功效和稳定性表明,SAMMS 也可作为口服药物和用于伤口去污。通过改变 SAMMS 的有机基团,它们不仅可用于锕系元素,还可用于其他放射性核素。通过使用这些 SAMMS 材料的混合物,非常可行的是对放射性核素进行广谱脱除。